In this story, Mehri Coulter, mental health advocate, describes her struggles with bipolar disorder and how she was ultimately able to achieve stability and happiness through pharmacogenomic testing. Mehri was not tested using an Illumina diagnostic test. She is sharing her story as a testimonial of the potential benefits of pharmacogenomics (PGx). One person’s experience is not predictive of results in other PGx cases, which may differ based on a variety of factors. Results in other cases may vary. Learn more about pharmacogenomics: https://www.illumina.com/PGx Follow Mehri Coulter: https://sobipolar.com/ Subscribe to the Illumina video channel http://www.youtube.com/subscription_c... M-GL-00370 A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. View customer spotlight videos https://www.youtube.com/playlist?list... View Illumina webinars https://www.youtube.com/playlist?list... View Illumina product videos https://www.youtube.com/playlist?list... View Illumina support videos https://www.youtube.com/playlist?list...